The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction

Beta blockers are a recommended therapy in patients with heart failure with reduced ejection fraction(HFrEF). Beta blockers markedly and unequivocally reduce mortality in patients with heart failure with reduced ejection fraction. However, the beneficial effects of beta blockers in patients with hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xizhen, Wang, Dao Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921146/
https://www.ncbi.nlm.nih.gov/pubmed/31886405
http://dx.doi.org/10.1016/j.ijcha.2019.100451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921146/
https://www.ncbi.nlm.nih.gov/pubmed/31886405
http://dx.doi.org/10.1016/j.ijcha.2019.100451

Ejemplares similares